Sino Biopharmaceutical Ltd
OTC:SBHMY
Sino Biopharmaceutical Ltd
OTC:SBHMY
Price:
15.89
USD
Market Cap:
$14.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
HK |
|
Shenzhen Goodix Technology Co Ltd
SSE:603160
|
CN |
|
I
|
Intel Corp
DUS:INL
|
US |
|
K
|
Klabin SA
BOVESPA:KLBN4
|
BR |
|
S
|
Sports Toto Bhd
KLSE:SPTOTO
|
MY |
|
C
|
Cadu Inmobiliaria SA de CV
BMV:CADUA
|
MX |
Multiples-Based Value
The Multiples-Based Value of one
SBHMY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 15.89 USD,
Sino Biopharmaceutical Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SBHMY Multiples-Based Value
LOCKED
Multiples Across Competitors
SBHMY Competitors Multiples
Sino Biopharmaceutical Ltd Competitors
Sino Biopharmaceutical Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
|
Sino Biopharmaceutical Ltd
OTC:SBHMY
|
108.1B USD | 3 | 40.7 | 12.2 | 12.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.9 | 43.9 | 29.6 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 17 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
